NCT07330882Enrolling by invitation
Health Behavior Management Program for Patients With Coronary Heart Disease
Health Behavior Management Program for Patients With Coronary Heart Disease: A Clinical Study
Source: ClinicalTrials.gov · Last updated 9 Jan 2026
Brief summary (registry, in English)
Coronary artery disease (CAD) is a major chronic condition severely impacting population health in China. Our previous cohort studies revealed a high comorbidity rate between CAD and frailty, suggesting their interrelated equivalence as clinical syndromes with shared risk factors. In recent years, pilot integrated health management initiatives in China have demonstrated promising outcomes, yet evidence remains scarce regarding patients with concurrent CAD and frailty-a critical gap needing urgent resolution to achieve the "Healthy China 2030" strategic goals. Building on prior research, this project aims to systematically evaluate existing management models for patients with CAD and frailty, develop a tailored health management framework, and implement it in clinical settings through empirical studies. The model will be optimized according to regional and demographic variations, leveraging cardiac rehabilitation centers, exercise-based interventions, and internet-enabled technologies to enhance coordinated care. By improving exercise efficacy, mitigating frailty progression, and enhancing quality of life, this initiative seeks to establish a robust chronic disease management system. The findings will provide evidence for formulating regional health policy and insurance strategies in Anhui Province, ultimately improving standardized management rates for chronic diseases.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 17 Nov 2025
- Start date
- 20 Oct 2024
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- The First Affiliated Hospital of Bengbu Medical University
- Diseases
- Coronary artery disease
- NCT number
- NCT07330882
What you commit to
- Study type: Interventional
- Planned participants: 200
- From 20 Oct 2024 to the primary completion date, 30 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concurrent severe comorbidities or malignancies, such as severe valvular heart disease, New York Heart Association class IV heart failure, severe aortic regurgitation, cancer, end-stage renal or liver disease;
Other illness
- Any other condition that could potentially impede exercise participation.
Other
- Inability or unwillingness to provide informed consent;
- Physical or cognitive limitations preventing app operation;
- Inability to attend in-person follow-up visits;
Who the study is looking for
- Diagnosis of Coronary heart disease;
- Proficiency in smartphone use;
- Absence of visual, auditory, cognitive, or motor impairments.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital of Bengbu Medical University Coordinator of this site? Confirm its status | Bengbu | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.